SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-041031
Filing Date
2024-05-09
Accepted
2024-05-09 08:00:46
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205096-10q_cormedix.htm   iXBRL 10-Q 554686
2 CERTIFICATION ea020509601ex31-1_cormedix.htm EX-31.1 9871
3 CERTIFICATION ea020509601ex31-2_cormedix.htm EX-31.2 10932
4 CERTIFICATION ea020509601ex32-1_cormedix.htm EX-32.1 4109
5 CERTIFICATION ea020509601ex32-2_cormedix.htm EX-32.2 4023
  Complete submission text file 0001213900-24-041031.txt   3888643

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20240331.xsd EX-101.SCH 32241
7 XBRL CALCULATION FILE crmd-20240331_cal.xml EX-101.CAL 35301
8 XBRL DEFINITION FILE crmd-20240331_def.xml EX-101.DEF 185139
9 XBRL LABEL FILE crmd-20240331_lab.xml EX-101.LAB 327992
10 XBRL PRESENTATION FILE crmd-20240331_pre.xml EX-101.PRE 179708
56 EXTRACTED XBRL INSTANCE DOCUMENT ea0205096-10q_cormedix_htm.xml XML 423315
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 24928678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)